Penn Medicine
Help | Search | Site Map | Contact   
faculty photo

Marissa B Wilck, MBChB, DTM&H, MS

Assistant Professor of Clinical Medicine
Attending Physician, Hospital of the University of Pennsylvania
Medical Director, Penn Home Infusion Therapy, University of Pennsylvania Health System
Transplant Infectious Diseases Fellowship Director, Perelman School of Medicine
Department: Medicine

Contact information
Hospital of the University of Pennsylvania
3400 Spruce Street
Silverstein, Suite D
Philadelphia, PA 19104
Office: 215 662 6932
Fax: 215 662 7899
Education:
MBChB (Medical Doctor)
Faculty of Health Sciences, University of Cape Town, South Africa , 1996.
DTM&H (Diploma in Tropical Medicine and Hygiene)
London School of Tropical Medicine and Hygiene, London, England, 1999.
MS (Masters in Health Sciences and Technology)
Harvard, MIT Division of Health Sciences and Technology, Beth Israel Deaconess Medical Center, Boston, MA, 2010.
Post-Graduate Training
Intern in Medicine, Groote Schuur Hospital, Cape Town, South Africa , 1997-1997.
Fellow in Clinical Microbiology, Yale New Haven Hospital, New Haven, CT , 1999-2000.
Intern in Medicine, Georgetown Program, Washington Hospital Center, Washington, DC , 2000-2001.
Resident in Medicine, Georgetown Program, Washington Hospital Center, Washington, DC , 2001-2003.
Chief Resident in Medicine, Georgetown Program, Washington Hospital Center, Washington, DC , 2003-2004.
Clinical Fellow in Medicine, Harvard Medical School Boston, MA , 2004-2005.
Clinical and Research Fellow in Infectious Diseases, Massachusetts General Hospital and Brigham and Women's Hospital, Boston, MA. , 2004-2006.
Certifications
Board Certified in Internal Medicine ABIM, 2004.
Board Certified in Infectious Diseases ABIM, 2006.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

D.E.Winetsky, J.Myers, S.Schulz, G.Tino, M.Wilck: A Case of Cavitary Pulmonary Mycobacterium Avium Intracellulare Infection in the Setting of Leflunomide Treatment. Letter to the Editor. Journal of Clinical Rheumatology 23(4): 231, June 2017.

Schneeweiss, Sebastian; Carver, Peggy; Datta, Kausik; Galar, Alicia; Johnson, Melissa; Johnson, Matthew; Marty, Francisco; Nagel, Jerod; Najdzinowicz, Maryann ; Saul, Melissa; Shoham, Shmuel; Silveira, Fernanda ; Varughese, Christine ; Wilck, Marissa; Weatherby, Lisa; Auton, Tim; Walker, Alexander: Short-term Risk of Liver and Renal Injury in Hospitalized Patients Using Micafungin – A Multicenter Cohort Study. Journal of Antimicrobial Chemotherapy 71(10): 2938-44, Oct 2016

Mills JP, Wilck MB, Weikert BC, Porrett PM, Timko D, Alby K, Bonomo RA, Blumberg EA.: Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen. Transpl Infect Dis 18(5): 777-781, Oct 2016

Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, Li F, Hertz T, Self SG, Friedrich D, Frahm N, Liao HX, Haynes BF, Montefiore DC, Tomaras GD, McElrath JM, Hura J, Graham BS, Jin X, HVTN 083 Study Group, NIAID HIV Vaccine Trials Network: Vaccination with heterologous HIV envelope sequences and heterologous adenovirus vectors increases T cell responses to conserved regions (HVTN 083). Journal of Infectious Disease 213(4): 541-50, Feb 15 2016.

Wine-Lee L, Keller SC, Wilck MB, Gluckman SJ, Van Voorhees AS: From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis. Journal of the American Academy of Dermatology 69(6): 1003-1013, Sep 2013.

Walsh SR, Wilck MB, Dominguez DJ, Zablowsky E, Bajimaya S, Gagne LS, Verrill KA, Kleinjan JA, Patel A, Zhang Y, Hill H, Acharyya A, Fisher DC, Antin JH, Seaman MS, Dolin R, Baden LR: Safety and immunogenicity of modified vaccinia ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. The Journal of Infectious Diseases 207(12): 1888-97, June 2013.

Kharfan-Dabaja MA, Boeckh M, Wilck MB, Langston AA, Chu AH, Wloch MK, Guterwill DF, Smith LR, Rolland AP, Kenney RT: A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases 12(4): 290-9, Apr 2012.

Wilck MB, Seaman MS, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Kleinjan JA, Noble LC, Stevenson KE, Kim HT, Dolin R.: Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration. Journal Infectious Diseases 201(9): 1361-1370, May 1 2010.

Seaman MS, Wilck MB, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Noble LC, Kleinjan JA, Stevenson KE, Kim HT, Dolin R: Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax. Journal of Infectious Diseases 201(9): 1353-1360, May 2010.

Wilck MB, Hamel MB, Baden LR: Clinical decisions. Management of incidental hepatitis C virus infection--polling results. The New England Journal of Medicine 360(23): e30, June 2009.

back to top
Last updated: 08/02/2017
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration